2011

Potential therapeutic target discovery by 2D-DIGE proteomic analysis in mouse models of asthma,
F. Quesada Calvo*, M. Fillet*, J. Renaut, C. Crahay, M. Gueders, J. Hacha, G. Paulissen, JM. Foidart, A. Noel, N. Rocks, P. Leprince, D. Cataldo.
*equally contribute to the work
J. Proteome Res. 10(9) (2011) 4291-4301. FI=5,460.

Pre-study and in-study validation of a SPE-LC-MS-MS method for the determination of 5-S-cysteinyldopa, a melamona biomarker, in human plasma,
G. Martin, F. Mansion, V. Houbart, Ph. Paquet, A. Rorive, P. Chiap, J. Crommen, AC. Servais, M. Fillet,
Talanta, 84 (2011) 280-286. FI=3,722.
(more…)

2010

Comparison of three methods for fractionation and enrichment of low molecular weight proteins for SELDI-TOF-MS differential analysis,
M. De Bock, D. de Seny, MA. Meuwis, AC. Servais, T. Quang Minh, J. Closset, JP. Chapelle, Ed. Louis, M. Malaise, MP. Merville and M. Fillet,
Talanta 82 (2010) 245-254. FI=3,290.

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS,
M. De Bock, D. de Seny, M-A. Meuwis, J-P. Chapelle, Ed. Louis, M. Malaise, M-P. Merville and M. Fillet,
Sous presse dans Journal of Biomedicine and Biotechnology, Volume 2010, Article ID 906082, 15 pages, doi:10.1155/2010/906082. Open Access. F.I. = 2,563

Critical analysis of several analytical method validation strategies in the framework of the fit for purpose concept,
A. Bouabidi, E. Rozet, M. Fillet, E. Ziemons, E. Chapuzet, B. Mertens, R. Klinkenberg, A. Ceccato, M. Talbi, B. Streel, A. Bouklouze, B. Boulanger, P. Hubert,
J. of Chromatogr. A, 1217(44) (2010) 3180-3192. F.I. = 4,101
(more…)

2009

CE-MS method development for peptides analysis, especially hepcidin, an iron metabolism marker,
G. B. Martin*, F. Mansion*, AC. Servais, B. Debrus, E. Rozet, Ph. Hubert, J. Crommen, M. Fillet,
*equally contribute to the work,
Electrophoresis 30(15) (2009) 2624-2631. F.I. =3,077

Biomarker discovery in asthma-related inflammation and remodeling,
F. Quesada Calvo*, M. Fillet*, D. de Seny, MA. Meuwis, R. Maree, C. Crahay, G. Paulissen, N. Rocks, M. Gueders, L. Wehenkel, MP. Merville, R. Louis, JM. Foidart, A. Noël, D. Cataldo,
*equally contribute to the work,
Proteomics 9(8) (2009) 2163-2170. F.I. = 4,586

The pro-apoptotic C16-ceramide-dependent pathway requires the death-promoting factor Btf in colon adenocarcinoma cells,
AF. Rénert, P. Leprince, M. Dieu, J. Renaut, M. Raes, V. Bours, JP. Chapelle, J. Piette, MP. Merville and M. Fillet,
Journal of Proteome Research, 8(10) (2009) 4810-4822. F.I. = 5,684
(more…)

2008

Determination of flurbiprofen enantiomers in plasma using a single-isomer amino cyclodextrin derivative in nonaqueous capillary electrophoresis,
A. Rousseau, M. Pedrini, P. Chiap, R. Ivanyi, J. Crommen, M. Fillet*, AC. Servais*, *equally contributed to the work,
Electrophoresis 29(17) (2008) 3641-3648. F.I. = 3,509

Proteomics for prediction and characterization of response to Infliximab in Crohn’s Disease: a pilot study,
M-A. Meuwis*, M. Fillet*, L. Lutteri, R. Marée, P. Geurts, D. de Seny, M. Malaise, JP. Chapelle, L. Wehenkel, J. Belaiche, MP. Merville and E. Louis,
*equally contributed to the work,
Clinical Biochemistry, 41(12) (2008) 960-967. F.I. = 1,926

Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis,
D. de Seny, M. Fillet, C. Ribbens, R. Marée, MA. Meuwis, L. Lutteri, JP. Chapelle, L. Wehenkel, Ed. Louis, MP. Merville, and M. Malaise,
Clinical Chemistry, 54(6) (2008) 1066-1075. F.I. = 5,579
(more…)